1Redon J,Olsen MH,Cooper RS,et al.Stroke mortality andtrends from 1990 to 2006 in 39 countries from Europe and CentralAsia:implications for control of high blood pressure[J].EurHeart J,2011,32:1424-1431.
2Kim AS,Johnston SC.Global variation in the relative burden ofstroke and ischemic heart disease[J].Circulation,2011,124:314-323.
6Jamieson DG.Secondary prevention of ischemic stroke:evolutionfrom a stepwise to a risk stratification approach to care[J].DisManag,2007,10:273-284.
7Ajjan RA,Grant PJ.The role of antiplatelets in hypertension anddiabetes mellitus[J].J Clin Hypertens(Greenwich),2011,13:305-313.
8Weber R,Weimar C,Diener HC.Medical prevention of strokeand stroke recurrence in patients with TIA and minor stroke[J].Expert Opin Pharmacother,2009,10:1883-1894.
9Badimon L,Vilahur G.Coronary atherothrombotic disease:pro-gress in antiplatelet therapy[J].Rev Esp Cardiol,2008,61:501-513.
10Kral M,Herzig R,Sanak D,et al.Oral antiplatelet therapy instroke prevention.Minireview[J].Biomed Pap Med Fac UnivPalacky Olomouc Czech Repub,2010,154:203-210.
